Overview

Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning

Status:
Unknown status

Trial end date:
2011-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to better understand brain function and psychiatric and neurological illness when taking Invega or Risperdal. The objective is to compare the brain effects of Invega to Risperdal in patients with Schizophrenia. This comparison will be evaluated with PET imaging, fMRI, and neurological ratings and assessments.

Phase:

Phase 4

Details

Lead Sponsor:

University of California, Irvine

Collaborator:

Janssen, LP

Treatments:

Paliperidone Palmitate
Risperidone